Toxic interactions of Romiplostim and Rituximab in normal and thrombocytopenic Rats
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immunologic destruction of normal platelets and insufficient production of platelets mediated by autoantibodies. And there are different treatment options for management of thrombocytopenia according to each case. Because of th...
Enregistré dans:
Auteurs principaux: | Saeed H., Sayed H.M., Ramadan A., Nahla S. Kotb |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Egyptian Society for Animal Management
2020
|
Sujets: | |
Accès en ligne: | https://dx.doi.org/10.21608/javs.2019.20470.1000 https://doaj.org/article/40c8ab91f9484ff08280bb1be8c50ce7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures
par: Robert Flisiak, et autres
Publié: (2021) -
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
par: Snigdha Nutalapati, et autres
Publié: (2021) -
First report on health-related quality of life among children with chronic immune thrombocytopenia in Vietnam
par: Sang Ngoc Nguyen, PhD, et autres
Publié: (2021) -
The pathophysiology of thrombocytopenia in chronic liver disease
par: Mitchell O, et autres
Publié: (2016) -
Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline
par: Wobke E. M. van Dijk, et autres
Publié: (2021)